Merck (NYSE:MRK) Faces Patent Lawsuit As Earnings Grow US$317 Million In Q1 [Yahoo! Finance]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Yahoo! Finance
The company reaffirmed its 2025 financial guidance, despite a slight decline in Q1 sales and ongoing patent litigation with Halozyme Therapeutics. Meanwhile, broader market movements, boosted by a tech-driven rally and anticipation of tariff news, provided a favorable backdrop. The market, seeing an overall 2.3% increase, suggested positive sentiment, possibly influenced by Merck's reinforced earnings outlook and the strong market performance across different sectors, aligning Merck's gains with these broader upward trends. Merck has 1 possible red flag we think you should know about. Uncover 13 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. The recent developments around Merck's (NYSE:MRK) reaffirmed 2025 financial guidance and patent litigation could potentially steer the company's future performance. This positive sentiment aligns with Merck's strategic focus on launching WINREVAIR and CAPVAXIVE, aiming to bolster it
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- SCHD vs. NOBL: Different Paths to Dividend Stability [Yahoo! Finance]Yahoo! Finance
- “Merck (MRK) is an Inexpensive Stock,” Says Jim Cramer [Yahoo! Finance]Yahoo! Finance
- Radiopharmaceutical specialist Aktis seeks an IPO [Yahoo! Finance]Yahoo! Finance
- SCHD vs. VYM: A Higher Yield Or High Total Return Potential [Yahoo! Finance]Yahoo! Finance
- SCHD Offers a Higher Yield While FDVV Grows Faster [Yahoo! Finance]Yahoo! Finance
MRK
Earnings
- 10/30/25 - Beat
MRK
Sec Filings
- 12/4/25 - Form 8-K
- 12/3/25 - Form 424B5
- 12/2/25 - Form FWP
- MRK's page on the SEC website